Estimates of case-fatality ratios of measles in low-income and middle-income countries: a systematic review and modelling analysis

Abstract

SummaryBackgroundIn the 21st century, increases in immunisation coverage and decreases in under-5 mortality have substantially reduced the global burden of measles mortality. However, the assessment of measles mortality burden is highly dependent on estimates of case-fatality ratios for measles, which can vary according to geography, health systems infrastructure, prevalence of underlying risk factors, and measles endemicity. With imprecise case-fatality ratios, there is continued uncertainty about the burden of measles mortality and the effect of measles vaccination. In this study, we aimed to update the estimations of case-fatality ratios for measles, to develop a prediction model to estimate case-fatality ratios across heterogeneous groupings, and to project future case-fatality ratios for measles up to 2030.MethodsWe did a review of the literature to identify studies examining measles cases and deaths in low-income and middle-income countries in all age groups from 1980 to 2016. We extracted data on case-fatality ratios for measles overall and by age, where possible. We developed and examined several types of generalised linear models and determined the best-fit model according to the Akaike information criterion. We then selected a best-fit model to estimate measles case-fatality ratios from 1990 to 2015 and projected future case-fatality ratios for measles up to 2030.FindingsWe selected 124 peer-reviewed journal articles published between Jan 1, 1980, and Dec 31, 2016, for inclusion in the final review—85 community-based studies and 39 hospital-based studies. We selected a log-linear prediction model, resulting in a mean case-fatality ratio of 2·2% (95% CI 0·7–4·5) in 1990–2015. In community-based settings, the mean case-fatality ratio was 1·5% (0·5–3·1) compared with 2·9% (0·9–6·0) in hospital-based settings. The mean projected case-fatality ratio in 2016–2030 was 1·3% (0·4–3·7).InterpretationCase-fatality ratios for measles have seen substantial declines since the 1990s. Our study provides an updated estimation of case-fatality ratios that could help to refine assessment of the effect on mortality of measles control and elimination programmes.FundingBill & Melinda Gates Foundation.

Estimating the Health Impact of Vaccination Against 10 Pathogens in 98 Low and Middle Income Countries from 2000 to 2030

“…Last, in making long-term projections of disease burden and intervention impact, it is necessary to make assumptions about the likely improvements in treatment and disease outcomes in future decades. This is a particular issue for HepB and HPV, where cancer screening and treatment services can make a substantial difference to disease-related mortality 18 , or for measles where decreasing background under-five mortality can significantly reduce case-fatality ratios 19 . The HPV and HepB models included in VIMC currently make conservative (i.e.…”

Vaccine confidence in the time of COVID-19

“…Like the present fixation with vaccines themselves, this attention to vaccine refusal has good reasons. Over the past two decades, global disease tracking has registered a significant rise in previously managed infectious diseases, measles being the celebrity example [8][9][10][11][12]. While there are competing hypotheses about the nature of this rise, the CDC-based on epidemiological data-has attributed it to reduced vaccination [13].…”

Measles virus infection diminishes preexisting antibodies that offer protection from other pathogens

“…Global measles vaccination efforts have led to logarithmic reductions in the incidence of measles virus (MV) infections and measles-related mortality. However, measles remains endemic in much of the world, affecting >7 million people annually and causing >100,000 deaths (1)(2)(3). After decades of decline, the number of worldwide cases of measles has increased by nearly 300% since 2018 as a result of reduced vaccination (2).…”